Literature DB >> 27079186

Pitfalls in Oncology: Osteoblastic Response Mimicking Bone Progression during Ceritinib Treatment in ALK-Rearranged NSCLC.

Francesco Gelsomino1, Valentina Ambrosini2, Barbara Melotti3, Francesca Sperandi3, Andrea Ardizzoni3.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2016        PMID： 27079186     DOI： 10.1016/j.jtho.2016.04.002

Source DB:  PubMed          Journal:  J Thorac Oncol        ISSN： 1556-0864            Impact factor:   15.609


× No keyword cloud information.
  3 in total

1.  Ultrasonic diagnosis combined with targeted ultrasound contrast agent improves diagnostic sensitivity of ultrasonic for non-small cell lung cancer patients.

Authors:  Xiaohong Zhang; Can Xiao
Journal:  Exp Ther Med       Date:  2018-05-23       Impact factor: 2.447

2.  [68Ga]Ga-DOTANOC Uptake at Pancreatic Head/Uncinate Process: Is It a Persistent Diagnostic Pitfall Over Time?

Authors:  Elena Tabacchi; Emilia Fortunati; Giulia Argalia; Lucia Zanoni; Diletta Calabrò; Silvi Telo; Davide Campana; Giuseppe Lamberti; Claudio Ricci; Riccardo Casadei; Stefano Fanti; Valentina Ambrosini
Journal:  Cancers (Basel)       Date:  2022-07-21       Impact factor: 6.575

3.  A Flare for the Unexpected: Bone Flare as Response to Tyrosine Kinase Inhibitor Treatment in a Lung Cancer Patient: New osteoblastic bone lesions in a lung cancer patient may represent bone flare and should not be misdiagnosed as disease progression.

Authors:  Charlotte De Bondt; Annemiek Snoeckx; Jo Raskin
Journal:  J Belg Soc Radiol       Date:  2020-04-27       Impact factor: 1.894
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.